Clinical Research

Pasithea Therapeutics Corp.

Address
2110 Narcissus Court

Sponsor Overview

assignment
1
sponsored trial
science
0
molecules
location_city
3
research centres
public
2
countries
person_search
2
investigators

Specializations

Oncology

Pasithea Therapeutics Corp. is involved in clinical research focused on solid tumors, with attention to advanced malignancies driven by MAPK pathway alterations. Its trial activity reflects interest in oncology settings where tumor biology is shaped by specific molecular changes.

  • Advanced solid tumors
  • MAPK pathway-driven cancers
  • RAS, NF1, and RAF mutations
  • BRAF/MEK inhibition-resistant disease

The sponsor’s research interest centers on targeted cancer therapy for patients with difficult-to-treat tumor types.

Molecularly Defined Cancer Subtypes

The clinical program includes patients selected for genomic alterations linked to tumor growth signaling, highlighting a focus on cancers defined by biomarker-driven characteristics rather than tumor site alone.

  • Genomic mutation–selected tumors
  • Signal transduction abnormalities
  • RAS pathway alterations
  • RAF-associated malignancies

This area of interest aligns with precision-oriented investigation in molecular oncology.

Sponsored Trials

Trial Name Country Status
Phase 1 Study of PAS-004, a MEK (1/2) Inhibitor, in MAPK Pathway-driven Advanced Solid Tumors with RAS, NF1, or RAF Mutations or Post-BRAF/MEK Inhibition FailureBulgaria BulgariaRomania RomaniaRecruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 0 total (0% not shared with other sponsors)

This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 3 sites collaborated multiple times

This sponsor has worked with 3 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Not possible to specify1 trial
    220 other sponsors

Partnered Research Centres

3 centres
location_city
assignment220
Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca
Address
Strada Republicii 34-36, 400015 Cluj Napoca
Learn morearrow_forward
location_city
assignment85
Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti
Address
Soseaua Fundeni 252, 022328 Bucharest
Learn morearrow_forward
location_city
assignment63
Multispecialty hospital for active treatment Sveta Sofia EOOD
Address
Bulevard Bilgariya 104, 1404 Sofia
Learn morearrow_forward

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Pasithea Therapeutics Corp..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.